People first
Quality care
Great service
Barclay Pharmaceuticals Ltd, established in 1976, is located at 48 Burlington House, Swanfield Road, Waltham Cross, United Kingdom, EN8 7FG. With a rich history spanning over three decades, we have developed an extensive and profound expertise in the field of movement disorders. Our long-standing commitment to this specialized area has enabled us to acquire a deep and comprehensive understanding of the complexities and nuances associated with these diseases. Our team’s extensive experience and knowledge underpin our dedication to advancing treatments and improving patient outcomes in the domain of movement disorders.
Our People
We are committed to making Barclay Pharmaceuticals Laboratories a better place to work. Our people are at the heart of everything we do, and we believe strongly in making their working life enjoyable, productive and worthwhile. In recent years we have launched numerous initiatives to improve our working environment
Collaboration
Barclay Pharmaceuticals Laboratories works actively with the scientific community, patient groups and payers to ensure our therapies reach the right patient at the right time and with the right level of care. But we take our wider responsibilities seriously, too – both from a CSR and a regulatory perspective.
We understand that pharma is evolving.
We believe it is no longer enough for companies to focus solely on drug development. Our goal is to provide a holistic solution both to patients and also the wider healthcare community.
Our years of experience in Parkinsons and other movement disorders have made us experts in patient therapy, but we are also committed to supporting our entire treatment programmes.
Our dedicated nursing team works closely with the NHS and other healthcare professionals to provide specialist care in complex disease areas. The nurses ensure families and carers are given the knowledge they need to better understand the treatments patients are receiving.
At all levels of our organisation, we are committed to providing quality of life to patients, value to payers and medical support to prescribers.